We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.12B
AUM Growth
+$72.9M
Cap. Flow
+$27.7M
Cap. Flow %
2.48%
Top 10 Hldgs %
21.95%
Holding
1,815
New
825
Increased
295
Reduced
449
Closed
98

Sector Composition

Rank Sector Weight
1 Technology 14.56%
2 Financials 13.71%
3 Healthcare 9.32%
4 Industrials 8.97%
5 Consumer Discretionary 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LDR
1326
DELISTED
Landauer Inc
LDR
$3K ﹤0.01%
55
SGBK
1327
DELISTED
Stonegate Bank
SGBK
$3K ﹤0.01%
+56
New +$2.54K
GUID
1328
DELISTED
Guidance Software, Inc.
GUID
$3K ﹤0.01%
+462
New +$3.15K
TRR
1329
DELISTED
Trc Companies
TRR
$3K ﹤0.01%
173
NYNY
1330
DELISTED
Empire Resorts, Inc.
NYNY
$3K ﹤0.01%
+137
New +$3.16K
PFSW
1331
DELISTED
PFSweb, Inc.
PFSW
$3K ﹤0.01%
528
+151
+40% +$1.14K
YELL
1332
DELISTED
Yellow Corporation Common Stock
YELL
$3K ﹤0.01%
244
AST
1333
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$3K ﹤0.01%
939
-1,261
-57% -$4.9K
BBOX
1334
DELISTED
Black Box Corp
BBOX
$3K ﹤0.01%
311
FPO
1335
DELISTED
First Potomac Realty Trust
FPO
$3K ﹤0.01%
+296
New +$3.04K
FRP
1336
DELISTED
Fairpoint Communications, Inc.
FRP
$3K ﹤0.01%
+203
New +$3.56K
ACRS icon
1337
Aclaris Therapeutics
ACRS
$816M
$2K ﹤0.01%
+72
New +$2.08K
AMSC icon
1338
American Superconductor
AMSC
$1.6B
$2K ﹤0.01%
+256
New +$1.72K
APVO icon
1339
Aptevo Therapeutics
APVO
$5.16M
0
ARDX icon
1340
Ardelyx
ARDX
$988M
$2K ﹤0.01%
+181
New +$2.38K
ARWR icon
1341
Arrowhead Research
ARWR
$12.2B
$2K ﹤0.01%
1,345
-670
-33% -$1.33K
ATLO icon
1342
AMES National
ATLO
$277M
$2K ﹤0.01%
+72
New +$2.3K
AVD icon
1343
American Vanguard Corp
AVD
$71.2M
$2K ﹤0.01%
+112
New +$1.86K
AXON
1344
Axon Enterprise
AXON
$45.4B
$2K ﹤0.01%
+104
New +$2.55K
AXSM icon
1345
Axsome Therapeutics
AXSM
$10.9B
$2K ﹤0.01%
525
-75
-13% -$358
BCRX icon
1346
BioCryst Pharmaceuticals
BCRX
$2.4B
$2K ﹤0.01%
288
-1,280
-82% -$8.9K
BPMC
1347
DELISTED
Blueprint Medicines
BPMC
$2K ﹤0.01%
+38
New +$1.36K
BW icon
1348
Babcock & Wilcox
BW
$1.4B
$2K ﹤0.01%
+23
New +$3.22K
BYD icon
1349
Boyd Gaming
BYD
$6.06B
$2K ﹤0.01%
+102
New +$2.07K
CCBG icon
1350
Capital City Bank Group
CCBG
$892M
$2K ﹤0.01%
+109
New +$2.24K

Similar funds

Meeder Asset Management's Q1 2017 Portfolio in Review

As of Q1 2017, Meeder Asset Management held 1,815 positions worth $1.12B, up 7% from $1.04B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Meeder Asset Management's Q1 2017 filing shows 825 new, 295 increased, 449 reduced and 98 closed positions. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 107,709 shares worth $13M. The largest sale was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $23.4M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Meeder Asset Management's largest Q1 2017 buy was iShares 20+ Year Treasury Bond ETF: 107,709 shares worth $13M.
  • Meeder Asset Management added most to iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2017, an estimated $30.3M increase.
  • Meeder Asset Management's biggest Q1 2017 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $23.4M.
  • Meeder Asset Management fully exited St Jude Medical in Q1 2017, selling an estimated $5.37M.
  • Meeder Asset Management's ten largest holdings make up 22% of its $1.12B portfolio in Q1 2017.
  • Meeder Asset Management opened 825 new positions and closed 98 in Q1 2017.
  • Meeder Asset Management's portfolio value rose 7% quarter-over-quarter to $1.12B.

Based on Meeder Asset Management's 13F filing for Q1 2017, filed 12 May 2017.